Cart is empty British pharmaceutical giant GSK said on Tuesday that the EU’s drug watchdog will study a new treatment for a common type of womb cancer for potential approval in the European market.
British pharmaceutical giant GSK said on Tuesday that the EU’s drug watchdog will study a new treatment for a common type of womb cancer for potential approval in the European market.
Leave A Comment